|
2016
|
Invention
|
Method of wound healing. The present invention relates to a method of treating a wound, comprisin... |
|
2015
|
Invention
|
Substituted bicyclic heteroaryl compounds as rxr agonists. The present invention relates to certa... |
|
2014
|
Invention
|
Spiro-substituted oxindole derivatives having ampk activity.
The present invention relates to co... |
|
2013
|
Invention
|
Use of tak1 inhibitor to achieve glycemic control in mammals.
The present invention relates to u... |
|
|
Invention
|
Use of adsl activator to achieve glycemic control in mammals.
The embodiments disclosed here in ... |
|
2012
|
Invention
|
Cyclic amide derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase and uses thereof. The... |
|
|
Invention
|
Derivatives of aza adamantane and uses thereof. The present invention relates to certain amide de... |
|
|
Invention
|
Cyclic amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase and uses thereof. ... |
|
|
Invention
|
Cyclic amide derivatives as inhibitors of 11 - beta - hydroxysteroid dehydrogenase and uses there... |
|
|
Invention
|
Process for the preparation of an aryl oxime and salts thereof. The invention relates to a proces... |
|
2011
|
Invention
|
Agonists of gpr40. The present invention relates to compounds that have the ability to modulate t... |
|
|
Invention
|
Composition and uses thereof. The present invention relates generally to pharmaceutical compositi... |
